Twenty-five years' experience treating cerebro-rhino-orbital mucormycosis.
Mucormycosis is an acute fungal disease with high mortality exhibiting craniofacial, pulmonary, cutaneous, gastrointestinal and disseminated forms. Cerebro-rhino-orbital (CRO) mucormycosis is the type that most frequently involves the structures of the head and neck. While usually non-pathogenic, these saprophytic organisms can be particularly lethal in chronically debilitated patients. Between the years 1957 and 1982, 18 cases of CRO mucormycosis were seen at the Medical College of Virginia Hospital and the McGuire VA Medical Center. Four illustrative cases of CRO mucormycosis are presented to emphasize: the importance of clinical awareness of the disease, the necessity of tissue biopsy for diagnosis, the need of appropriate management of any underlying disorder, administration of amphotericin-B, and the performance of adequate surgery.
D000328:Adult; D000368:Aged; D000666:Amphotericin B / Q000627:therapeutic use*; D001927:Brain Diseases / Q000188:drug therapy / Q000601:surgery / Q000628:therapy*; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009091:Mucormycosis / Q000188:drug therapy / Q000601:surgery / Q000628:therapy*; D009668:Nose Diseases / Q000188:drug therapy / Q000601:surgery / Q000628:therapy*; D009916:Orbital Diseases / Q000188:drug therapy / Q000601:surgery / Q000628:therapy*
D000666:Amphotericin B